SEA-CD70

N/A

Report date: 2025/06/17 11:42:11

Base Information

Drug NameSEA-CD70
Drug Alias NameSEA-CD70PF-08046040
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCD70 antigen inhibitors
TargetsCD70 antigen
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsMainland China +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSeagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeagen IncPfizer IncBeOne Medicines Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A